인슐린 투여 기기 시장 규모, 점유율, 성장 분석 : 제품 유형별, 당뇨병 유형별, 최종사용자별, 지역별 - 업계 예측(2025-2032년)

Global Insulin Delivery Devices Market size was valued at USD 16.7 billion in 2023 and is poised to grow from USD 18.02 billion in 2024 to USD 33.11 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global market for insulin delivery devices is experiencing significant growth driven by the rising prevalence of diabetes. This surge in demand is prompting the development of advanced, user-friendly diabetes management systems. The integration of digital technologies, particularly Continuous Glucose Monitoring (CGM) systems, is enhancing insulin delivery by enabling real-time adjustments of insulin doses based on continuous blood glucose monitoring. Additionally, wearable and patch insulin pumps are gaining traction, offering discreet and convenient methods for administering continuous insulin infusion. Innovations in this sector, such as new applications for cutting-edge patch insulin pump systems, highlight the ongoing advancements in technology, further propelling market expansion and improving patient experiences in diabetes management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Delivery Devices Market Segments Analysis

Global Insulin Delivery Devices Market is segmented by Product Type, Diabetes Type, End-User and region. Based on Product Type, the market is segmented into Insulin Pens, Insulin Pumps (Tethered), Insulin Pumps (Tubeless / Patch), Insulin Syringes & Needles and Smart Insulin Delivery Devices. Based on Diabetes Type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other Special Populations. Based on End-User, the market is segmented into Home Care / Self-administration, Hospitals & Clinics and Specialized Diabetes Care Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Delivery Devices Market

The global market for insulin delivery devices is being significantly propelled by the emergence of interoperable ecosystems that integrate insulin delivery systems with continuous glucose monitors (CGMs), smartphone applications, smart pens, and connected pumps. This integration enhances dosing precision, bolsters patient adherence to treatment plans, and facilitates remote monitoring by healthcare providers, thereby reducing the frequency of hypoglycemic events and lowering hospital visits. Additionally, growing reimbursement opportunities for telehealth and digital diabetes management programs are paving the way for more connected devices within home care and outpatient settings, fostering greater confidence among clinicians and promoting a sense of comfort for patients.

Restraints in the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market faces significant challenges due to the high costs associated with devices and their consumables, especially with automated pumps and integrated systems, which limits accessibility for price-sensitive regions. Variations in reimbursement policies across different regions further impede the adoption of these technologies, resulting in delays when coverage is restricted. This reluctance from payers to endorse emerging technologies, such as patch pumps and closed-loop systems, poses barriers to market entry. For broader coverage and affordability, manufacturers must demonstrate the value and feasibility of their offerings to gain the necessary support from healthcare payers.

Market Trends of the Global Insulin Delivery Devices Market

The global insulin delivery devices market is witnessing a significant trend towards the adoption of smaller, tubeless patch pumps, reflecting a user preference for streamlined and convenient solutions. These innovative systems simplify insulin administration, thereby enhancing the quality of life for diabetic patients. As advancements in technology lead to the incorporation of smartphone controls and automated algorithms, the appeal of these devices is growing, particularly among individuals hesitant to use traditional pumps. This shift not only supports better management of diabetes but also indicates a broader movement within the market towards more patient-centric, user-friendly insulin delivery methods.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Insulin Delivery Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Insulin Pens
• Insulin Pumps (Tethered)
• Insulin Pumps (Tubeless / Patch)
• Insulin Syringes & Needles
• Smart Insulin Delivery Devices

Global Insulin Delivery Devices Market Size by Diabetes Type & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Other Special Populations

Global Insulin Delivery Devices Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Home Care / Self-administration
• Hospitals & Clinics
• Specialized Diabetes Care Centres

Global Insulin Delivery Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Diabetes Type, End-User)
  • US
  • Canada
• Europe (Product Type, Diabetes Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Diabetes Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Diabetes Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Diabetes Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Diabetes Care Division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Diabetes Care)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Diabetes Solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (Integrated pump solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nippon Boehringer Ingelheim Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations